Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer Prevention
Scientists at University of Texas, Department of Clinical Sciences discuss research in cervical cancer prevention
December 17th, 2008
New investigation results, 'Human papillomavirus and cervical cancer behavioral surveillance in the US,' are detailed in a study published in Cancer. According to a study from the United States, "In the US, federal and state behavioral surveillance systems routinely monitor self-reported sexual behavior and Papanicolaou (Pap) test use to identify high-risk populations, trends, and disparities and to guide and evaluate interventions for cervical cancer prevention and control. Clinical uptake of human papillomavirus (HPV) vaccination and testing necessitates the expansion of behavioral surveillance systems." "Cervical disease is the main focus of HPV-related...
Source: Vaccine Weekly (2008-12-17)
|
